Comparison of Immediate and 2-Year Outcomes between Excimer Laser-Assisted Angioplasty with Spot Stent and Primary Stenting in Intermediate to Long Femoropopliteal Disease. (5th December 2013)
- Record Type:
- Journal Article
- Title:
- Comparison of Immediate and 2-Year Outcomes between Excimer Laser-Assisted Angioplasty with Spot Stent and Primary Stenting in Intermediate to Long Femoropopliteal Disease. (5th December 2013)
- Main Title:
- Comparison of Immediate and 2-Year Outcomes between Excimer Laser-Assisted Angioplasty with Spot Stent and Primary Stenting in Intermediate to Long Femoropopliteal Disease
- Authors:
- Wu, Tien-Yu
Chou, Hsin-Hua
Chang, Shang-Hung
Tsai, Yueh-Ju
Hsieh, Chien-An
Cheng, Shih-Tsung
Yeh, Kuan-Hung
Chang, Hern-Jia
Ko, Yu-Lin
Huang, Hsuan-Li - Other Names:
- Noonan D. Academic Editor.
Razavi M. K. Academic Editor.
Shagdarsuren E. Academic Editor. - Abstract:
- Abstract : Background . To compare the clinical outcomes between excimer laser-assisted angioplasty (ELA) with spot stent (group A) and primary stenting (group B) in intermediate to long femoropopliteal disease. Methods . Outcomes of 105 patients totaling 119 legs treated with two different strategies were analyzed retrospectively in a prospectively maintained database. Results . Baseline characteristics were similar in both groups. Better angiographic results and lesser increase of serum C-reactive protein levels (0.60 ± 0.72 versus 2.98 ± 0.97 mg/dL, P < 0.001 ) after the intervention were obtained in Group B. Group A had inferior 1-year outcomes due to higher rate of binary restenosis (67% versus 32%, P = 0.001 ) and lower rate of primary patency (40% versus 58%, P = 0.039 ). Rates of amputation-free survival, target vessel revascularization, assisted primary patency, and stent fracture at 24 months were similar in both groups (80% versus 82%, P = 0.979, 65% versus 45%, P = 0.11, 78% versus 80%, P = 0.75 and 6.3% versus 6.8%, P = 0.71, resp.). Conclusion . Greater vascular inflammation after ELA with spot stent resulted in earlier restenosis and inferior 1-year clinical outcomes than primary stenting. This benefit was lost in the primary stenting group at 2 years due to late catch-up restenosis. Active surveillance with prompt intervention was required to maintain the vessel patency.
- Is Part Of:
- TheScientificWorldjournal. Volume 2013(2013)
- Journal:
- TheScientificWorldjournal
- Issue:
- Volume 2013(2013)
- Issue Display:
- Volume 2013, Issue 2013 (2013)
- Year:
- 2013
- Volume:
- 2013
- Issue:
- 2013
- Issue Sort Value:
- 2013-2013-2013-0000
- Page Start:
- Page End:
- Publication Date:
- 2013-12-05
- Subjects:
- Science -- Periodicals
Technology -- Periodicals
Medicine -- Periodicals
505 - Journal URLs:
- https://www.hindawi.com/journals/tswj/biblio/ ↗
- DOI:
- 10.1155/2013/247102 ↗
- Languages:
- English
- ISSNs:
- 2356-6140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 10280.xml